AtriCure Inc (ATRC) - Total Liabilities
Based on the latest financial reports, AtriCure Inc (ATRC) has total liabilities worth $152.29 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore AtriCure Inc (ATRC) net asset momentum to track the company's year-over-year net asset growth rate.
AtriCure Inc - Total Liabilities Trend (2001–2025)
This chart illustrates how AtriCure Inc's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of AtriCure Inc to measure how efficiently the company converts operating cash flow to free cash.
AtriCure Inc Competitors by Total Liabilities
The table below lists competitors of AtriCure Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bangkok Life Assurance Public Company Limited
BK:BLA
|
Thailand | ฿270.08 Billion |
|
Xinyu Iron & Steel Co Ltd
SHG:600782
|
China | CN¥21.63 Billion |
|
Tibet Tianlu Co Ltd
SHG:600326
|
China | CN¥6.63 Billion |
|
Chongqing Chuanyi Automation Co Ltd
SHG:603100
|
China | CN¥4.15 Billion |
|
Guangdong Ellington Electronics Technology Co Ltd
SHG:603328
|
China | CN¥2.33 Billion |
|
Pearl Abyss Corp
KQ:263750
|
Korea | ₩319.76 Billion |
|
NÜRNBERGER Beteiligungs-AG
F:NBG6
|
Germany | €36.59 Billion |
|
Nations Technologies Inc
SHE:300077
|
China | CN¥2.59 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down AtriCure Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ATRC market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AtriCure Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AtriCure Inc (2001–2025)
The table below shows the annual total liabilities of AtriCure Inc from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $162.24 Million | +9.36% |
| 2024-12-31 | $148.36 Million | +0.40% |
| 2023-12-31 | $147.76 Million | +14.82% |
| 2022-12-31 | $128.69 Million | -2.18% |
| 2021-12-31 | $131.56 Million | -56.46% |
| 2020-12-31 | $302.14 Million | -2.70% |
| 2019-12-31 | $310.54 Million | +189.20% |
| 2018-12-31 | $107.38 Million | +0.79% |
| 2017-12-31 | $106.54 Million | -1.33% |
| 2016-12-31 | $107.98 Million | +24.97% |
| 2015-12-31 | $86.41 Million | +234.06% |
| 2014-12-31 | $25.87 Million | -34.26% |
| 2013-12-31 | $39.34 Million | +97.40% |
| 2012-12-31 | $19.93 Million | +9.25% |
| 2011-12-31 | $18.24 Million | +7.45% |
| 2010-12-31 | $16.98 Million | -5.10% |
| 2009-12-31 | $17.89 Million | +25.56% |
| 2008-12-31 | $14.25 Million | +44.89% |
| 2007-12-31 | $9.83 Million | +16.61% |
| 2006-12-31 | $8.43 Million | +23.00% |
| 2005-12-31 | $6.86 Million | -82.88% |
| 2004-12-31 | $40.06 Million | +18.89% |
| 2003-12-31 | $33.70 Million | +5853.36% |
| 2002-12-31 | $566.00K | +76.88% |
| 2001-12-31 | $320.00K | -- |
About AtriCure Inc
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; m… Read more